Tango Therapeutics (TNGX) EPS (Weighted Average and Diluted) (2021 - 2025)
Historic EPS (Weighted Average and Diluted) for Tango Therapeutics (TNGX) over the last 5 years, with Q3 2025 value amounting to $0.13.
- Tango Therapeutics' EPS (Weighted Average and Diluted) rose 14814.81% to $0.13 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.92, marking a year-over-year increase of 2068.97%. This contributed to the annual value of -$1.19 for FY2024, which is 1088.63% down from last year.
- Latest data reveals that Tango Therapeutics reported EPS (Weighted Average and Diluted) of $0.13 as of Q3 2025, which was up 14814.81% from -$0.35 recorded in Q2 2025.
- Tango Therapeutics' EPS (Weighted Average and Diluted)'s 5-year high stood at $0.13 during Q3 2025, with a 5-year trough of -$0.36 in Q1 2025.
- Over the past 5 years, Tango Therapeutics' median EPS (Weighted Average and Diluted) value was -$0.3 (recorded in 2022), while the average stood at -$0.27.
- Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first tumbled by 21111.11% in 2022, then surged by 14814.81% in 2025.
- Tango Therapeutics' EPS (Weighted Average and Diluted) (Quarter) stood at -$0.36 in 2021, then increased by 7.07% to -$0.33 in 2022, then rose by 1.47% to -$0.33 in 2023, then dropped by 5.95% to -$0.34 in 2024, then soared by 137.74% to $0.13 in 2025.
- Its EPS (Weighted Average and Diluted) stands at $0.13 for Q3 2025, versus -$0.35 for Q2 2025 and -$0.36 for Q1 2025.